» Articles » PMID: 32508807

Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation

Overview
Journal Front Immunol
Date 2020 Jun 9
PMID 32508807
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Proteoglycans are a specific subset of glycoproteins found at the cell surface and in the extracellular matrix, where they interact with a plethora of proteins involved in metabolic homeostasis and meta-inflammation. Over the last decade, new insights have emerged on the mechanism and biological significance of these interactions in the context of diet-induced disorders such as obesity and type-2 diabetes. Complications of energy metabolism drive most diet-induced metabolic disorders, which results in low-grade chronic inflammation, thereby affecting proper function of many vital organs involved in energy homeostasis, such as the brain, liver, kidney, heart and adipose tissue. Here, we discuss how heparan, chondroitin and keratan sulfate proteoglycans modulate obesity-induced metabolic dysfunction and low-grade inflammation that impact the initiation and progression of obesity-associated morbidities.

Citing Articles

The role of the extracellular matrix in cardiac regeneration.

Wang X, Yu S, Xie L, Xiang M, Ma H Heliyon. 2025; 11(1):e41157.

PMID: 39834404 PMC: 11745795. DOI: 10.1016/j.heliyon.2024.e41157.


Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males.

Moqaddam M, Nemati M, Dara M, Hoteit M, Sadek Z, Ramezani A Nutrients. 2024; 16(17).

PMID: 39275173 PMC: 11397083. DOI: 10.3390/nu16172857.


Obesity-associated inflammatory macrophage polarization is inhibited by capsaicin and phytolignans.

Poynter M, Mank M, Ather J Am J Physiol Regul Integr Comp Physiol. 2024; 326(5):R370-R382.

PMID: 38436058 PMC: 11398870. DOI: 10.1152/ajpregu.00161.2023.


Unraveling adipose tissue proteomic landscapes in severe obesity: insights into metabolic complications and potential biomarkers.

Hruska P, Kucera J, Kuruczova D, Buzga M, Pekar M, Holeczy P Am J Physiol Endocrinol Metab. 2023; 325(5):E562-E580.

PMID: 37792298 PMC: 10864023. DOI: 10.1152/ajpendo.00153.2023.


SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System Parameters.

Pepin X, Grant I, Wood J Pharm Res. 2023; 40(9):2195-2214.

PMID: 37634241 PMC: 10547635. DOI: 10.1007/s11095-023-03567-0.


References
1.
Edwards I, Xu H, Wright M, Wagner W . Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thromb. 1994; 14(7):1032-9. DOI: 10.1161/01.atv.14.7.1032. View

2.
Zhu H, Pan H, Cui Y, Wang X, Wang L, Li N . The changes of serum glypican4 in obese patients with different glucose metabolism status. J Clin Endocrinol Metab. 2014; 99(12):E2697-701. DOI: 10.1210/jc.2014-2018. View

3.
Mauviel A, Santra M, Chen Y, Uitto J, Iozzo R . Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. J Biol Chem. 1995; 270(19):11692-700. DOI: 10.1074/jbc.270.19.11692. View

4.
Heisler L, Lam D . An appetite for life: brain regulation of hunger and satiety. Curr Opin Pharmacol. 2017; 37:100-106. DOI: 10.1016/j.coph.2017.09.002. View

5.
Saltiel A, Olefsky J . Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1):1-4. PMC: 5199709. DOI: 10.1172/JCI92035. View